Risk factors

Three years too long for PAH diagnosis

Sponsored by Actelion Pharmaceuticals

For patients with pulmonary arterial hypertension (PAH) an early diagnosis and referral to a PAH centre of excellence are the factors most likely to make a difference in patient outcomes, says eminent researcher and clinical director of the Heart Research Institute, Professor David Celermajer. But for many patients it can take up to three years1 ...

Already a member?

Login to keep reading.

© 2021 the limbic